Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, et al. · JAMA · 2021-09-28
Notice: this source has been marked corrected. Detected 2026-11-11. ErratumIn: JAMA. 2026 May 12;335(18):1640. doi: 10.1001/jama.2025.20680. (PMID 41989770) Initial import 2026-11-11: metadata from PubMed, approved for the index as Research indexed (no summary).
This entry is research indexed. We have confirmed the source details below and link to the original. Plain-language and professional summaries appear here only after a qualified clinician has reviewed them.
Source details
| Authors | US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, et al. |
|---|---|
| Journal or publisher | JAMA |
| Published | 2021-09-28 |
| DOI | 10.1001/jama.2021.14781 |
| PMID | 34581729 |
| Document type | Guideline or consensus statement |
| Full text | See the PubMed record for publisher links |
| Licensing | Linked only. Not reproduced. |
| Added to library | November 11, 2026 |
| Details last verified | November 11, 2026 |
Questions to bring to your doctor
- Does this guidance or study apply to my situation? Why or why not?
- Has anything newer replaced it?
- How does it change what you recommend for us?
Research describes groups of people and cannot predict the outcome for one pregnancy or one child. Report a problem with this entry